These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 11406188)
1. Novel AMPA receptor potentiators LY392098 and LY404187: effects on recombinant human AMPA receptors in vitro. Miu P; Jarvie KR; Radhakrishnan V; Gates MR; Ogden A; Ornstein PL; Zarrinmayeh H; Ho K; Peters D; Grabell J; Gupta A; Zimmerman DM; Bleakman D Neuropharmacology; 2001 Jun; 40(8):976-83. PubMed ID: 11406188 [TBL] [Abstract][Full Text] [Related]
2. Pharmacological effects of AMPA receptor potentiators LY392098 and LY404187 on rat neuronal AMPA receptors in vitro. Gates M; Ogden A; Bleakman D Neuropharmacology; 2001 Jun; 40(8):984-91. PubMed ID: 11406189 [TBL] [Abstract][Full Text] [Related]
3. Positive modulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptors in prefrontal cortical pyramidal neurons by a novel allosteric potentiator. Baumbarger PJ; Muhlhauser M; Zhai J; Yang CR; Nisenbaum ES J Pharmacol Exp Ther; 2001 Jul; 298(1):86-102. PubMed ID: 11408529 [TBL] [Abstract][Full Text] [Related]
4. LY392098, a novel AMPA receptor potentiator: electrophysiological studies in prefrontal cortical neurons. Baumbarger P; Muhlhauser M; Yang CR; Nisenbaum ES Neuropharmacology; 2001 Jun; 40(8):992-1002. PubMed ID: 11406190 [TBL] [Abstract][Full Text] [Related]
5. LY404187: a novel positive allosteric modulator of AMPA receptors. Quirk JC; Nisenbaum ES CNS Drug Rev; 2002; 8(3):255-82. PubMed ID: 12353058 [TBL] [Abstract][Full Text] [Related]
6. Potentiation of responses to AMPA on central neurones by LY392098 and LY404187 in vivo. Vandergriff J; Huff K; Bond A; Lodge D Neuropharmacology; 2001 Jun; 40(8):1003-9. PubMed ID: 11406191 [TBL] [Abstract][Full Text] [Related]
7. Multiple molecular determinants for allosteric modulation of alternatively spliced AMPA receptors. Quirk JC; Nisenbaum ES J Neurosci; 2003 Nov; 23(34):10953-62. PubMed ID: 14645491 [TBL] [Abstract][Full Text] [Related]
8. Stable expression of recombinant AMPA receptor subunits: binding affinities and effects of allosteric modulators. Hennegriff M; Arai A; Kessler M; Vanderklish P; Mutneja MS; Rogers G; Neve RL; Lynch G J Neurochem; 1997 Jun; 68(6):2424-34. PubMed ID: 9166736 [TBL] [Abstract][Full Text] [Related]
9. AMPA receptor potentiators for the treatment of CNS disorders. O'Neill MJ; Bleakman D; Zimmerman DM; Nisenbaum ES Curr Drug Targets CNS Neurol Disord; 2004 Jun; 3(3):181-94. PubMed ID: 15180479 [TBL] [Abstract][Full Text] [Related]
10. Regulation of BDNF expression in primary neuron culture by LY392098, a novel AMPA receptor potentiator. Legutko B; Li X; Skolnick P Neuropharmacology; 2001 Jun; 40(8):1019-27. PubMed ID: 11406193 [TBL] [Abstract][Full Text] [Related]
11. Activity of 2,3-benzodiazepines at native rat and recombinant human glutamate receptors in vitro: stereospecificity and selectivity profiles. Bleakman D; Ballyk BA; Schoepp DD; Palmer AJ; Bath CP; Sharpe EF; Woolley ML; Bufton HR; Kamboj RK; Tarnawa I; Lodge D Neuropharmacology; 1996; 35(12):1689-702. PubMed ID: 9076748 [TBL] [Abstract][Full Text] [Related]